View all news

BTC collaborator COVID-19 projects

Press release issued: 6 May 2020


The Bristol Trials Centre has many collaborators who work with us on our studies, providing specific support and guidance. We have highlighted below some of the great research that BTC collaborators are carrying out into COVID-19.

The DECIDE study - DEcision making about Cancer treatment during the covID 19 pandEmic.

Led by Daisy Elliott

The overall aim of this project is to investigate formulation and delivery of cancer treatment recommendations in the context of the COVID-19 pandemic, with a view to producing evidence-informed resources to support communication in clinician-patient encounters.

Specific objectives are to:

  • Investigate processes for organising and prioritising cancer treatment during the COVID-19 pandemic in NHS Trusts across the UK, including clinical professionals’ experiences of implementing national and specialty-specific guidance;
  • Examine cancer treatment discussions conducted between clinical professionals and patients through audio-recording clinical consultations;
  • Explore patients’ and clinical professionals’ experiences of the above clinical encounters and their perceptions of how these can be improved;
  • Use the evidence generated from the above to produce resources designed to support communication around cancer treatment in the context of the COVID-19 pandemic.

The Lotus C19 Study - Understanding perceptions of risks, mitigation and innovation for surgery in a COVID-19 world.

Led by Leila Rooshenas

We will conduct in-depth, semi-structured interviews to understand the perceived risks in surgery in the context of COVID-19 and explore strategies to overcome these. We will examine present experiences in the NHS and the international response by surgical teams.

COVID-19 rapid evidence reviews - co-ordinated by the National Institute for Health Research Applied Research Collaboration West (NIHR ARC West).

The Bristol Trials Centre is one of several research centres from across the University of Bristol, University of the West of England and University of Bath to be collaborating with NIHR ARC West to provide rapid evidence reviews for COVID-19 response planning. These reviews offer expertise across various settings and topics to inform decision-making for NHS clinical commissioning groups (CCGs), local authority public health departments and the Department of Health and Social Care in their response to the COVID-19 pandemic. Settings include mental health, primary care, care homes, acute trusts and community, with a range of topics covered across those settings. Dr Peter Brindle, Medical Director at the Bristol, North Somerset and South Gloucestershire CCG, said: “These rapid reviews are just one example of how the academic community has rallied to support the health and care system in the COVID-19 crisis. It is incredible how responsive university colleagues have been in providing evidence and evaluation support.” The rapid evidence reviews are available on the NIHR ARC West website:

Edit this page